Enhanced expression of cyclooxygenase-2 in glaucomatous dog eyes |
| |
| Authors: | Marshall Janene L Stanfield Kristina M Silverman Lee Khan K Nasir M |
| |
| Institution: | Pfizer Research &Development, 4901 Searle Parkway, Skokie, IL 60077, USA,;Department of Veterinary Biosciences, The Ohio State University Veterinary Teaching Hospital, Columbus, OH 43210, USA |
| |
| Abstract: | Objective Cyclooxygenase‐2 (COX‐2)‐derived prostaglandins (PGs) are shown to play important pathophysiologic roles in various disease states. Recently, the effectiveness of topical PGs in reducing intraocular pressure (IOP) has stimulated further interest in the physiologic function of COX‐2 and PGs in normal and glaucomatous eyes. Therefore, we investigated the cell‐type distribution and expression of COX‐2 in normal and glaucomatous dog eyes. Procedures Using isoform‐specific antibodies, we immunohistochemically evaluated COX‐2 expression in formalin‐fixed and paraffin‐embedded normal (n = 5) and glaucomatous (n = 17) dog eyes. Results In the normal eyes, only minimal COX‐2 immunoreactivity was observed in the ciliary epithelium. In the glaucomatous eyes, COX‐2 expression was further observed in the cornea and corneoscleral limbus. In the cornea, moderate to strong COX‐2 expression was observed in all corneal layers (epithelium, stromal cells and endothelium), with the greatest expression present in the epithelial layer. In the corneoscleral limbus area, COX‐2 immunoreactivity was noted in the stromal cells of sclera, trabecular meshwork and endothelial cells of the angular aqueous plexus. Conclusions Increased expression of COX‐2 in dog glaucomatous eyes suggests that COX‐2‐derived PGs may have a potential role in the pathogenesis of canine glaucoma. |
| |
| Keywords: | cyclooxygenase-2 dog eye glaucoma prostaglandins |
| 本文献已被 PubMed 等数据库收录！ |
|
